Title:
A mTOR inhibitor, herceptin, and/or anti-malignant tumor combination of HKI-272
Document Type and Number:
Japanese Patent JP6040303
Kind Code:
B2
Abstract:
A combination of temsirolimus and herceptin in the treatment of cancer is provided. A combination of temsirolimus and HKI-272 is provided. A combination of herceptin and HKI-272 is also provided. Regimens and kits for treatment of metastatic breast cancer, containing herceptin, temsirolimus and/or HKI-272, optionally in combination with other anti-neoplastic agents, or immune modulators are described.
Inventors:
Lawrence Moore
Charles Tsaharchuk
Sridhar Krishna Rabindran
Charles Tsaharchuk
Sridhar Krishna Rabindran
Application Number:
JP2015255873A
Publication Date:
December 07, 2016
Filing Date:
December 28, 2015
Export Citation:
Assignee:
Weiss LRC
International Classes:
A61K31/337; A61K31/4709; A61K31/436; A61K45/00; A61P35/00; A61P35/04
Domestic Patent References:
| JP2004532883A | ||||
| JP2004525950A |
Foreign References:
| WO2004004644A2 |
Other References:
Cancer Research,2004年,Vol.64, No.11,p.3958-3965
Attorney, Agent or Firm:
Hidesaku Yamamoto
Natsuki Morishita
Natsuki Morishita